PeproTech Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, K.
Right arrow Articles by Yamanaka, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, K.
Right arrow Articles by Yamanaka, H.
(Journal of Leukocyte Biology. 2001;69:531-537.)
© 2001 by Society for Leukocyte Biology

NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer

Kazuhiro Suzuki, Haruki Nakazato, Hiroshi Matsui, Masaru Hasumi, Yasuhiro Shibata, Kazuto Ito, Yoshitatsu Fukabori, Kohei Kurokawa and Hidetoshi Yamanaka

Department of Urology, Gunma University School of Medicine, Maebashi, Japan

Correspondence: Kazuhiro Suzuki, M.D., Department of Urology, Gunma University School of Medicine, 3-39-22, Showa-machi, Maebashi, 371-8511, Japan. E-mail: kazu{at}showa.gunma-u.ac.jp

Interleukin (IL)-15 is a pleiotropic cytokine that is important for innate and adaptive immune cell homeostasis. The expression of IL-15 protein is controlled by posttranscriptional mechanisms. Here, we constructed a human IL-15 expression vector consisting of the human IL-2 signal peptide, the human IL-15 mature peptide-coding sequences, and an out-of-frame human growth hormone gene. Human prostate cancer cells, PC-3, transfected with this highly secretable form of the IL-15 gene, successfully secreted abundant bioactive IL-15 protein. In nude mice, the growth of PC-3 cells producing IL-15 was remarkably retarded. NK cell-depletion using anti-asialo GM1 antibody restored tumorigenicity. Histologically, tumors derived from IL-15-producing PC-3 cells contained necrotic areas with high apoptotic index. Splenocytes incubated with supernatant of transfectants killed target PC-3 cells and expressed a significantly high level of mIFN-{gamma} mRNA. These observations suggest that NK cell-mediated, anti-tumor effects of IL-15 could provide a potential rationale for gene therapy of prostate cancer.

Key Words: cellular immunity • chimeric peptide • murine IFN • anti-asialo GM1




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
D. L. Blum, T. Koyama, A. E. M'Koma, J. M. Iturregui, M. Martinez-Ferrer, C. Uwamariya, J. A. Smith Jr., P. E. Clark, and N. A. Bhowmick
Chemokine Markers Predict Biochemical Recurrence of Prostate Cancer following Prostatectomy
Clin. Cancer Res., December 1, 2008; 14(23): 7790 - 7797.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. L. Sutherland, B. Rabinovich, N. J. Chalupny, P. Brawand, R. Miller, and D. Cosman
ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15
Blood, August 15, 2006; 108(4): 1313 - 1319.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Yokoyama, H. Nakanishi, Y. Kodera, Y. Ikehara, N. Ohashi, Y. Ito, M. Koike, M. Fujiwara, M. Tatematsu, and A. Nakao
Biological Significance of Isolated Tumor Cells and Micrometastasis in Lymph Nodes Evaluated Using a Green Fluorescent Protein-Tagged Human Gastric Cancer Cell Line
Clin. Cancer Res., January 15, 2006; 12(2): 361 - 368.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Yajima, H. Nishimura, S. Sad, H. Shen, H. Kuwano, and Y. Yoshikai
A Novel Role of IL-15 in Early Activation of Memory CD8+ CTL after Reinfection
J. Immunol., March 15, 2005; 174(6): 3590 - 3597.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. L. Cook, T. A. Miura, D. N. Ikle, A. M. Lewis Jr., and J. M. Routes
E1A Oncogene-induced Sensitization of Human Tumor Cells to Innate Immune Defenses and Chemotherapy-induced Apoptosis in Vitro and in Vivo
Cancer Res., June 15, 2003; 63(12): 3435 - 3443.
[Abstract] [Full Text] [PDF]